Medtech startup Nami Surgical has opened a $10M Series A funding round. The company previously raised seed funding in 2024 and has spent the past 18 months advancing its team and core technology.
Contentlockr
Glasgow-based Nami Surgical, a medtech startup developing the world’s first miniaturised ultrasonic scalpel for robotic-assisted surgery, has announced the opening of its $10M (nearly €8.62M) Series A funding round.
The round, launched in July 2025, is expected to close by December 2025. According to the company, it has already received support from existing investors. The funding will support global scaling, product development, and advancement of the company’s patented ultrasonic technology.
Founded in 2023, Nami Surgical previously raised $4.3M in seed funding in 2024. Over the past 18 months, the company has expanded its leadership team, advanced product development, and validated its core technology through preclinical testing.
Investor partnership opportunity
Nami Surgical is seeking investors with experience in surgical robotics and medical device hardware to support its growth.
The funding will be used to launch a soft-tissue robotic-assisted surgical platform, scale R&D for high-volume prototyping and testing, explore applications in bone-tissue surgery, and strengthen the leadership team for global commercialisation and partnerships.
Dr Nico Fenu, co-founder and CEO of Nami Surgical, says, “We are now fully focused on our Series A round—an important and defining moment for our team.”
“This funding will unlock an exciting phase of commercial partnerships and shape what’s possible for our ultrasonic platform across multiple verticals. It will allow us to expand our capabilities, strengthen our already exceptional team, and move decisively toward our goal of bringing Nami’s core technology into operating rooms globally.”
Nami Surgical is inviting investors with experience in the robotic-assisted surgical sector to explore potential partnerships and collaborate on the development and commercialisation of its technology.
Technology for robotic-assisted surgery
Ultrasonic scalpels are vital in minimally invasive procedures for dissecting tissue, cauterising, and sealing blood vessels. However, their large size has prevented integration into robotic surgical systems, as they cannot fit into wristed robotic joints. This has been a key barrier to bringing ultrasonic technology into robotic-assisted surgery.
Founded by Nico Fenu and Rebecca Cleary, Nami Surgical has developed the world’s first miniaturised ultrasonic scalpel that integrates with robotic joints, fits through standard 8mm surgical ports, and is fully articulated within the body. This enables faster, safer, and more precise robotic procedures.
In addition to the scalpel, the company has engineered a modular ultrasonic driving system that precisely controls energy delivery to the surgical site. Clinical testing has shown performance comparable to market leaders, despite the device being over 90 per cent smaller than current commercial alternatives.
